Systematic pan-cancer analysis identified RASSF1 as an immunological and prognostic biomarker and validated in lung cancer
Yibing Bai(Chinese PLA General Hospital), Yi Hu, Ting Wang(University of Science and Technology of China), Jinfeng Li(Hebei Medical University), Jinliang Wang(Tianjin University), Xin Zhou(Affiliated Hospital of Southwest Medical University), Zhiqiang Ma(Second Military Medical University), Jiapei Qin(Chinese PLA General Hospital), Yuanyong Wang(Weifang Medical University), Wenyu Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), An Wang(Gansu Agricultural University)
Cited by 3
Related Papers
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218